Psychedelics Psychedelic Therapeutics & Drug Development Conference kicks off in New Orleans It is being hosted in tandem with the International Society for Research on Psychedelics Biennial Conference Rowan DunneFebruary 26, 2026
Psychedelics African psilocybin cultivator ‘Psyence’ gets C$600K investment The final C$124,000-dollar tranche was obtained on Jul. 4 Rowan DunneJuly 10, 2025
Medical and Pharmaceutical Investors flock to psychedelic start-ups Sovereign wealth funds Temasek and Mubadala engage in discussions to finance biotech ventures Zartasha MushtaqFebruary 12, 2024
Health & Wellness Compass Pathways, Hackensack Meridian Health collaborate on psilocybin treatment research Partnership signals a milestone agreement for innovative treatment solutions Zartasha MushtaqJanuary 19, 2024
News American Medical Association approves medical code for psychedelic therapies coverage The code was the result of a partnership between U.K.-based COMPASS Pathways and the Multidisciplinary Association for Psychedelic Studies (MAPS) Natalia Buendia CalvilloMay 3, 2023
News MindMed stock surges on Nasdaq listing approval After its stock jumped 66%, MindMed now rivals Compass Pathways as the world's most valuable psychedelic company Jared GnamApril 23, 2021
Medical and Pharmaceutical Psilocybin treats depression as well as common antidepressant: study The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine Jared GnamApril 15, 2021
Psychedelics 2020’s top 5 advancements in psychedelics With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field Jared GnamDecember 30, 2020